Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126009421 | 12600942 | 1 | I | 201508 | 20160720 | 20160728 | 20160728 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-060789 | BRISTOL MYERS SQUIBB | 63.99 | YR | M | Y | 0.00000 | 20160728 | CN | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126009421 | 12600942 | 1 | PS | REYATAZ | ATAZANAVIR SULFATE | 1 | Oral | UNK | Y | 21567 | |||||||||
126009421 | 12600942 | 2 | SS | NORVIR | RITONAVIR | 1 | Oral | UNK | Y | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126009421 | 12600942 | 1 | HIV infection |
126009421 | 12600942 | 2 | HIV infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126009421 | 12600942 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126009421 | 12600942 | Cholestasis | |
126009421 | 12600942 | Hepatocellular injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126009421 | 12600942 | 1 | 20050316 | 20150826 | 0 | |
126009421 | 12600942 | 2 | 20050316 | 20150826 | 0 |